Lesaffre and Recombia Biosciences to Advance Innovative Gene Editing technology through a strategic partnership Recombia Biosciences aims to harness its proprietary genome editing technologies to accelerate the development of yeast for sustainable production of fermented ingredients. For the next few…
Gnosis by Lesaffre strives to create a world that lives better thanks to micro-organisms and biotransformation. And to make this vision a reality, our Business Unit recently unveiled its new commercial strategy. Improving human health and well-being. Gnosis by Lesaffre…
Procelys by Lesaffre invites you to its very first edition of the Fermentation Masters on the theme: “How to produce quality probiotics and stand out in a booming market?”. A virtual event featuring 5 talks live broadcasted on LiveStorm from…
On 19th of September, at the end of its annual general meeting, Lesaffre’s Board of Directors elected Thibaut de Ladoucette as Chairman, to replace Lucien Lesaffre, Chairman of the Board of Directors since 2012 and having reached the statutory age…
Fermentation is at the heart of our activities. We are convinced that it is one of the solutions to meet the challenges facing humanity, in particular: how to feed 10 billion people healthily in 2050? We are already on the…
As a global key player recognized for its expertise in the field of yeast and yeast extracts, Lesaffre has been developing for several years in the world of micro-organisms and fermentation. Today, the group is unveiling a new territory of…
